Moderna (MRNA)
Health Care · mRNA therapeutics and vaccines
Moderna is an unprofitable mRNA vaccine and therapeutic company pivoting from peak COVID revenues with a diversified pipeline facing intense competition and declining sales.
What Moderna does
Moderna develops and commercializes mRNA-based vaccines and therapeutics for infectious diseases, oncology, and rare diseases. The company manufactures its mRNA products at its own facilities and through third-party partners. Following a significant decline from COVID-19 peak revenues, Moderna is focused on advancing its clinical pipeline and establishing market acceptance for next-generation vaccines and cellular therapies, while managing its cost structure as it transitions from pandemic-driven sales.
Themes: ["mRNA platform","vaccine development","oncology/cancer immunotherapy","personalized medicine","infectious disease vaccines","clinical stage programs","manufacturing scale-up"]
Fundamentals
- Price$76.56 as of 2026-07-09 close
- Market cap$30.3B as of 2026-07-10
- 1-year return+133.5% as of 2026-07-09 close
- Net margin-143.6% as of 2026-07-10
- Gross margin+35.0% as of 2026-07-10
- ROE-36.7% as of 2026-07-10
- Debt / equity0.09 as of 2026-07-10
- Revenue growth (YoY)-30.0% as of 2026-07-10
- Revenue CAGR (3y)-53.4% SEC XBRL
- Beta0.86 as of 2026-07-10
Key risks (from latest filing)
["Steep revenue decline of -30% YoY and persistent unprofitability with -144% net margin, reliant on limited revenue base from legacy COVID vaccines and early-stage product launches","Intense competitive vaccine market and execution risk on late-stage pipeline programs, with regulatory approval uncertainty and clinical trial delays potentially impacting commercialization timeline","Manufacturing complexity and supply chain dependencies, particularly for personalized therapies like intismeran autogene which require single-patient custom production processes and novel manufacturing approaches"]
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.